📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer (2017)

First Author: Shimelis H

Attributed to: King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-16-2568

PubMed Identifier: 28283652

Publication URI: http://europepmc.org/abstract/MED/28283652

Type: Journal Article/Review

Parent Publication: Cancer Research

Issue: 11

ISSN: 0008-5472